74 related articles for article (PubMed ID: 19255303)
21. Increasing long-term survival in advanced colorectal cancer.
Verghese M; Pathak S; Poston GJ
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S1-4. PubMed ID: 18036766
[No Abstract] [Full Text] [Related]
22. Expanded criteria for surgery for liver metastases: thoughtful science or diamond mining?
Wagman LD
J Clin Oncol; 2008 Aug; 26(22):3663-4. PubMed ID: 18669448
[No Abstract] [Full Text] [Related]
23. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
[TBL] [Abstract][Full Text] [Related]
24. Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases.
Davies JM; Goldberg RM
J Surg Oncol; 2010 Dec; 102(8):946-54. PubMed ID: 21165997
[TBL] [Abstract][Full Text] [Related]
25. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
Yoo PS; Lopez-Soler RI; Longo WE; Cha CH
Clin Colorectal Cancer; 2006 Sep; 6(3):202-7. PubMed ID: 17026789
[TBL] [Abstract][Full Text] [Related]
26. Optimizing resection for "responding" hepatic metastases after neoadjuvant chemotherapy.
Thomay AA; Charpentier KP
J Surg Oncol; 2010 Dec; 102(8):1002-8. PubMed ID: 20734423
[TBL] [Abstract][Full Text] [Related]
27. Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
Garant A; Des Groseilliers S; Martin L; Ferland É; Vuong T
Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):497-8. PubMed ID: 21576010
[No Abstract] [Full Text] [Related]
28. Volumetric analysis of remnant liver regeneration after major hepatectomy in bevacizumab-treated patients: a case-matched study in 82 patients.
Millet G; Truant S; Leteurtre E; Hebbar M; Zerbib P; Huet G; Boleslawski E; Pruvot FR
Ann Surg; 2012 Nov; 256(5):755-61; discussion 761-2. PubMed ID: 23095619
[TBL] [Abstract][Full Text] [Related]
29. [Results of resection and adjuvant therapy of liver metastases of primary colorectal tumors--a review of the literature].
Lorenz M; Staib-Sebler E; Rossion I; Koch B; Gog C; Encke A
Zentralbl Chir; 1995; 120(10):769-79. PubMed ID: 7502591
[TBL] [Abstract][Full Text] [Related]
30. Changing paradigms for liver resection of colorectal metastases.
Kemeny NE
Ann Surg Oncol; 2012 Sep; 19(9):2773-5. PubMed ID: 22752377
[No Abstract] [Full Text] [Related]
31. [Liver histology and surgical outcomes after preoperative chemotherapy in colorectal cancer liver metastases].
Hisaka T; Horiuchi H; Uchida S; Ishikawa H; Ogata Y; Akagi Y; Ishibashi N; Kawahara R; Maruyama Y; Mikagi K; Kawashima Y; Fujishita M; Eto D; Yoshidomi M; Yamaguchi R; Kage M; Yano H; Kinoshita H; Shirozu K
Gan To Kagaku Ryoho; 2011 Apr; 38(4):585-9. PubMed ID: 21498986
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-induced steatohepatitis in colorectal cancer patients.
Gentilucci UV; Santini D; Vincenzi B; Fiori E; Picardi A; Tonini G
J Clin Oncol; 2006 Dec; 24(34):5467; author reply 5467-8. PubMed ID: 17135651
[No Abstract] [Full Text] [Related]
33. Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version.
Zalinski S; Mariette C; Farges O; ; ;
J Visc Surg; 2011 Jun; 148(3):e171-82. PubMed ID: 21703959
[No Abstract] [Full Text] [Related]
34. [Roles of hepatectomy for colorectal liver metastases with necrotic foci caused by prior anti-cancer therapies].
Ko S; Mukogawa T; Ishikawa H; Inoue T; Nishiwada T; Nakamoto T; Kunishige T; Watanabe A
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2569-72. PubMed ID: 21224642
[TBL] [Abstract][Full Text] [Related]
35. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.
Aussilhou B; Dokmak S; Faivre S; Paradis V; Vilgrain V; Belghiti J
Ann Surg Oncol; 2009 Jun; 16(6):1553-9. PubMed ID: 19363584
[TBL] [Abstract][Full Text] [Related]
36. [Two radically resected colorectal carcinoma cases with unresectable liver metastasis after adjuvant chemotherapy with bevacizumab].
Sugiyama M; Kakeji Y; Kubo N; Nakanoko T; Fujinaka Y; Ando K; Masuda T; Yagi K; Yoshinaga K; Saeki H; Endo K; Emi Y; Morita M; Maehara Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2169-71. PubMed ID: 20037359
[TBL] [Abstract][Full Text] [Related]
37. The role of chemotherapy in the curative treatment of patients with liver metastases from colorectal cancer.
Leichman L
Surg Oncol Clin N Am; 2007 Jul; 16(3):537-56, viii-ix. PubMed ID: 17606193
[TBL] [Abstract][Full Text] [Related]
38. [Surgical quality assurance exemplified by surgical therapy of colorectal carcinoma].
Lippert H; Gastinger I
Chirurg; 1995 Apr; 66(4):344-9. PubMed ID: 7634945
[TBL] [Abstract][Full Text] [Related]
39. Bevacizumab-induced hypovascular hepatocellular carcinoma treated by transarterial chemoembolization in a patient with metastatic colon cancer.
Iwazawa J; Ohue S; Hashimoto N; Yasumasa K; Abe H; Mitani T
J Vasc Interv Radiol; 2010 Mar; 21(3):412-4. PubMed ID: 20116287
[No Abstract] [Full Text] [Related]
40. Management of surgical challenges in actively treated cancer patients.
Santos DA; Alseidi A; Shannon VR; Messick C; Song G; Ledet CR; Lee H; Ngo-Huang A; Francis GJ; Asher A
Curr Probl Surg; 2017 Dec; 54(12):612-654. PubMed ID: 29421024
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
